UK's plan to hike drugmaker rebates reflects 'broken' system, pharma group says
The UK government is planning to double the proportion of money drugmakers have to pay back on medicine sales to the National Health Service in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
